Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Autologous haematopoietic stem-cell transplantation versus bortezomib–melphalan–prednisone, with or without bortezomib–lenalidomide–dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study

Autor: Cavo, M. Gay, F. Beksac, M. Pantani, L. Petrucci, M.T. Dimopoulos, M.A. Dozza, L. van der Holt, B. Zweegman, S. Oliva, S. van der Velden, V.H.J. Zamagni, E. Palumbo, G.A. Patriarca, F. Montefusco, V. Galli, M. Maisnar, V. Gamberi, B. Hansson, M. Belotti, A. Pour, L. Ypma, P. Grasso, M. Croockewit, A. Ballanti, S. Offidani, M. Vincelli, I.D. Zambello, R. Liberati, A.M. Andersen, N.F. Broijl, A. Troia, R. Pascarella, A. Benevolo, G. Levin, M.-D. Bos, G. Ludwig, H. Aquino, S. Morelli, A.M. Wu, K.L. Boersma, R. Hajek, R. Durian, M. von dem Borne, P.A. Caravita di Toritto, T. Zander, T. Specchia, G. Waage, A. Gimsing, P. Mellqvist, U.-H. van Marwijk Kooy, M. Minnema, M. Mandigers, C. Cafro, A.M. Palmas, A. Carvalho, S. Spencer, A. Boccadoro, M. Sonneveld, P.

Background: The emergence of highly active novel agents has led some to question the role of autologous haematopoietic stem-cell transplantation (HSCT) and subsequent consolidation therapy in newly diagnosed multiple myeloma. We therefore compared au

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2127::0239ec2b87d37fdf26b7139dd667c9a3
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3121066

'Real-life' analysis of the role of antifungal prophylaxis in preventing invasive aspergillosis in AML patients undergoing consolidation therapy: Sorveglianza Epidemiologica Infezioni nelle Emopatie (SEIFEM) 2016 study

Autor: Del Principe MI, Dragonetti, G, Verga, L, Candoni, A, Marchesi, F, Cattaneo, C, Delia, M, Potenza, L, Farina, F, Ballanti, S, Decembrino, N, Castagnola, C, Nadali, G, Fanci, R, Orciulo, E, Veggia, B, Offidani, M, Melillo, L, Manetta, S, Tumbarello, M, Venditti, A, Busca, A, Aversa, F, Pagano, L

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______310::132f950c152bc2c32770c499f986c773
http://hdl.handle.net/2158/1179484

Lenalidomide Maintenance with or without Prednisone in Newly Diagnosed Myeloma Patients: A Pooled Analysis

Autor: Bonello, F., Pulini, S., Ballanti, S., Gentile, M., Spada, S., Annibali, O., Omede, P., Ronconi, S., Cangialosi, C., Podda, L., Palmas, A., Malfitano, A., Rivoli, G., Belotti, A., Ciambelli, F., Vincelli, I. D., Cafro, A. M., Innao, V., Palumbo, A., Sonneveld, P., Spencer, A., Hajek, R., Boccadoro, M., Gay, F.

Publikováno v: Cancers, Vol 11, Iss 11, p 1735 (2019)
Cancers
Cancers, 11(11):1735. Multidisciplinary Digital Publishing Institute (MDPI)
Volume 11
Issue 11

We conducted a pooled analysis of two phase III trials, RV-MM-EMN-441 and EMN01, to compare maintenance with lenalidomide-prednisone vs. lenalidomide in newly diagnosed transplant-eligible and -ineligible myeloma patients. Primary endpoints were prog

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fdcb616a3a39f42ce9199aa113c277a4
https://doi.org/10.3390/cancers11111735

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.